Frontline therapies for adult patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia: a systematic literature review.

Blincyto (blinatumomab) - Amgen

Rituxan (rituximab) - Roche

Besponsa (inotuzumab ozogamicin) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42711755

Christian Stefan Eichinger; Diana Boyko; Faraz Zaman; Maria Virginia Meza; Sarah Hodgkinson

Sep 10, 2026